Table 3 Cardiac parameters of HD patients and control subjects.

From: Quantification of extracellular volume fraction by cardiac computed tomography for noninvasive assessment of myocardial fibrosis in hemodialysis patients

 

HD (n = 20)

Control (n = 20)

P value

LVEDV (mL)

105.0 ± 40.6

99.2 ± 19.7

0.74

LVEDVI (mL/m2)

64.6 ± 26.9

59.2 ± 14.4

0.84

LVESV (mL)

48.4 ± 30.6

36.3 ± 11.5

0.55

LVESVI (mL/m2)

29.7 ± 19.9

21.6 ± 7.5

0.55

LVEF (%)

57.1 ± 13.3

64.6 ± 5.7

0.15

LVM* (g)

148.0 ± 45.2

107.1 ± 18.8

< 0.001

LVMI* (g/m2)

90.9 ± 28.9

64.5 ± 11.0

< 0.0001

LAV* (ml)

85.4 ± 41.3

50.7 ± 16.8

< 0.0001

LAVI* (ml/m2)

51.9 ± 22.4

30.2 ± 10.4

< 0.0001

  1. All data are shown as mean ± standard deviation.
  2. HD hemodialysis, ECV extracellular volume fraction, LAV left atrial volume, LAVI left atrial volume index, LVM left ventricular mass, LVMI left ventricular mass index, LVEF left ventricular ejection fraction, LVEDV left ventricular end-diastolic volume, LVEDVI left ventricular end-diastolic volume index, LVESV left ventricular end-systolic volume, LVESVI left ventricular end-systolic volume index, DLP dose-length product.
  3. *P < 0.05.
Back to article page